Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

3(50%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 2Efficacy & side effects

6(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(2)

Other(1)

Detailed Status

Completed2

Recruiting2

Active, not recruiting1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 26 (100.0%)

Trials by Status

active_not_recruiting117%

completed233%

recruiting233%

unknown117%

Recent Activity

3 active trials

Showing 5 of 6

recruitingphase_2

Clinical Trials (6)

Showing 6 of 6 trials

NCT07220408Phase 2

Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis

Recruiting

NCT06686472Phase 2

Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis

Recruiting

NCT06225973Phase 2

A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease

Active Not Recruiting

NCT06293820Phase 2

A Study Of TL-925 For The Treatment of AC

Completed

NCT06153342Phase 2

A Study of TL-925 for the Treatment of Allergic Conjunctivitis

Unknown

NCT05745064Phase 2

A Study of TL-925 as a Treatment for Dry Eye Disease

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6